Hello NB - as always you have the good oil - been discussing the...

Hello NB - as always you have the good oil - been discussing the release of the data from the phase 2 with the sp movement being the possible reason and the upcoming SNO but the timeline doesn't work IMO - the clinical trials website has the estimated end of trial data as the 30th of November - a week after the SNO. Reading back I found your post and agree that this endcaps the timeline AND JG must have known that this was going to work because you posted this on the 5th of October ie this was from that date at the latest.
The next question is what comes after the SNO (18-21 November) but well before January 19th 2022 or is this data going to simply be released to market as a PS with a likely TH here and in the US..?